Molecular Features of Metanephric Adenoma and Their Values in Differential Diagnosis

X Wang,S,W R Yang,S B Ye,R Li,H,R S Zhang,Z F Lu,X J Zhou,Q Rao

DOI: https://doi.org/10.3760/cma.j.issn.0529-5807.2017.01.009

2017-01-01

Abstract:Objective To study the molecular features of metanephric adenoma ( MA) and discuss their values in differential diagnosis .Methods BRAF V600E immunohistochemistry ( IHC) using the mutation-specific VE1 monoclonal antibody and Sanger sequencing of BRAF mutations were performed on 21 MAs, 16 epithelial-predominant Wilms tumors ( e-WT) and 20 the solid variant of papillary renal cell carcinomas ( s-PRCC ) respectively.p16 protein was detected by IHC also.Fluorescence in situ hybridization ( FISH) analyses using centromeric probes for chromosome 7 and 17 were performed on the three renal tumors in parallel.Results Fourteen (14/21,66.7%) of 21 MA cases demonstrated diffuse , moderate to strong cytoplasmic BRAF V600E IHC staining and the BRAF V600E protein expression was detected in 2 (2/16) of 16 e-WT cases for the first time, whereas all s-PRCCs were negative (P<0.05). All cases (including 14 MAs and 2 e-WTs) with diffuse, moderate to strong cytoplasmic BRAF V600E IHC staining were confirmed to harbor BRAF V600E missense mutations using Sanger sequencing , and no BRAF mutations were detected in cases with negative BRAF V 600E protein expression.One case (1/21,4.8%) showed trisomy of chromosome 7 alone, and another one (1/21,4.8%) showed trisomy of chromosome 17 alone in 21 MAs.Two cases ( 2/16 ) of 16 e-WTs showed trisomy of chromosome 17 alone.In 20 s-PRCCs, trisomy of chromosomes 7 alone was reported in 2 cases (2/20), trisomy of chromosome 17 alone in 3 cases (3/20) and trisomy of chromosome 7 and 17 in 14 cases (14/20).The total positive rates of trisomy of chromosome 7 and/or 17 in MAs, e-WTs and s-PRCCs were 9.6% (2/21), 2/16 and 95.0%(19/20).p16 protein was positive in 81.0% (17/21) MAs, whereas the positive rates in e-WTs and s-PRCCs were 2/16 and 5.0% (1/20).Conclusions Most MAs harbor BRAF V600E mutations, and MAs lack the gains of chromosome 7 and 17 that are characteristic of papillary renal cell carcinoma.These molecular features can be used to distinguish MA from its mimics.BRAF V600E IHC using the mutation-specific VE1 monoclonal antibody provides an effective method in BRAF V 600E mutations detection of renal tumors.p16 is overexpressed in MA , and the finding suggests that the low proliferative rate of the tumor might be attributed to BRAF V600E-induced senescence mediated by p 16.